A) Primary objective:~Gathering knowledge on the use of Dymista® in Asian patients who receive Dymista® for the first time in routine clinical practice; Patient's demographic;~Anamnestic background including:~allergic and other comorbidities~allergic conjunctivitis~polysensitization~current symptoms~previous treatments of allergic rhinitis~usage of current asthma reliever medication~family history of allergy~B) Secondary Objective:~Response to therapy with Dymista® nasal spray in routine clinical practice.~Quality of sleep (by VAS)~Troublesomeness in daily activities (by VAS)~Patient's assessment about the regular use of Dymista®~Patients opinion about continuation of Dymista® treatment after end of the observational period
Gathering knowledge on the use of Dymista® in Asian patients who receive Dymista® for the first time in routine clinical practice